Search for: "HI-TECH PHARMACEUTICALS, INC."
Results 101 - 120
of 144
Sorted by Relevance
|
Sort by Date
8 Sep 2014, 10:02 pm
The defendants, who ran an operation known as Hi-Tech Pharmaceuticals Inc., continued to deceptively market weight-loss products in violation of a 2008 federal court order, with unsubstantiated claims such as “rapid fat loss,” “fat burner,” “thermogenic” and “curbs the appetite. [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP) Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) Events 26 August:… [read post]
19 Sep 2018, 11:28 am
Anthem, Inc.[25] But the evidence is plenty. [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro (Escitalopram)… [read post]
4 Jun 2007, 12:56 am
ALM Privacy Policy / Contact Us
© 2007 ALM Properties, Inc. [read post]
30 Jun 2022, 4:02 pm
“Gene Levoff betrayed the trust of one of the world’s largest tech companies for his own financial gain,” Attorney for the United States Khanna said. [read post]
28 Mar 2008, 6:00 am
- Anonymity of policy research group quoted on pharma patenting policy and stats: (Spicy IP),Thailand: More news/reactions on compulsory licenses: (Generic Pharmaceuticals & IP),US: Follow-on biologic drugs and patent law: A potential disconnect? [read post]
28 Nov 2023, 5:24 am
Levine, 555 U.S. 555 (2009) Mutual Pharmaceutical Co., Inc. v. [read post]
29 Mar 2010, 5:00 am
United Techs. [read post]
11 Nov 2021, 2:07 pm
I would like to thank Nessim for allowing me to publish his article as a guest post on this site. [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
31 Mar 2017, 9:00 am
Barron had little familiarity with pharmaceuticals and received little training from SafeTrust and IntegraRx. [read post]
13 Apr 2014, 8:59 am
Apotex Inc. v. [read post]
11 May 2020, 1:09 am
Juries did just fine on whether Farmer Brown had exercised due care when he ran over his neighbor’s cow with his tractor, or even when a physician opined that a child was born 350 days after the putative father’s death was sired by the testator and entitled to inherit from “dad. [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation amendments to dodge real story:… [read post]
12 Oct 2007, 12:57 am
ALM Privacy Policy / Contact Us
© 2007 ALM Properties, Inc. [read post]
1 Jun 2010, 8:16 am
He was the lead trial lawyer for Forest Laboratories Inc. in an effort to block Teva Pharmaceutical Industries Ltd. from selling a generic version of the antidepressant Lexapro. [read post]
27 Sep 2009, 2:30 pm
Turn-Key-Tech, LLC, 381 F.3d 1142, 1149 (Fed. [read post]
12 Aug 2016, 4:49 pm
Low tolerance for borrowing in paintings; high tolerance for borrowing in pharmaceuticals. [read post]
9 May 2008, 10:30 pm
, US: ACI ‘In-house counsel forum on pharmaceutical antitrust’ – 20-21 May, Maryland: (Orange Book Blog), EU: Workshop for mediators in IP disputes – 26-27 May, Geneva: (IPR-Helpdesk), US: PLI: ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – 28 May, New York / 11 June, San Francisco: (Patent Docs), US: Worldwide Business Research: PharmaBiotech IP summit –… [read post]
